Zero-Inflated Models for Identifying Relationships Between Body Mass Index and Gastroesophageal Reflux Symptoms: A Nationwide Population-Based Study in China.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 26993823)

Published in Dig Dis Sci on March 18, 2016

Authors

Qin Xu1, Wei Zhang2, Tianyi Zhang1, Ruijie Zhang3, Yanfang Zhao1, Yuan Zhang1, Yibin Guo1, Rui Wang1, Xiuqiang Ma4, Jia He5

Author Affiliations

1: Department of Health Statistics, Second Military Medical University, Shanghai, China.
2: Department of Health Services Management, Second Military Medical University, Shanghai, China.
3: General Office, Binzhou Central Hospital, Binzhou, China.
4: Department of Health Statistics, Second Military Medical University, Shanghai, China. horse_ma88@yeah.net.
5: Department of Health Statistics, Second Military Medical University, Shanghai, China. hejia63@yeah.net.

Articles cited by this

Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet (2004) 39.54

Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med (1999) 17.30

Epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut (2005) 7.35

Guidelines for the diagnosis and management of gastroesophageal reflux disease. Am J Gastroenterol (2013) 6.82

Meta-analysis: obesity and the risk for gastroesophageal reflux disease and its complications. Ann Intern Med (2005) 4.52

Global burden of cancer attributable to high body-mass index in 2012: a population-based study. Lancet Oncol (2014) 4.00

Body mass index and risk of adenocarcinomas of the esophagus and gastric cardia. J Natl Cancer Inst (1998) 3.66

Methods for analyzing health care utilization and costs. Annu Rev Public Health (1999) 3.63

Obesity is an independent risk factor for GERD symptoms and erosive esophagitis. Am J Gastroenterol (2005) 3.34

Association between body mass and adenocarcinoma of the esophagus and gastric cardia. Ann Intern Med (1999) 3.31

Prevalence of Obesity Among Adults and Youth: United States, 2011-2014. NCHS Data Brief (2015) 3.10

Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut (2013) 2.96

Obesity and estrogen as risk factors for gastroesophageal reflux symptoms. JAMA (2003) 2.77

Risk factors associated with symptoms of gastroesophageal reflux. Am J Med (1999) 2.75

The relation of gastroesophageal reflux disease and its treatment to adenocarcinomas of the esophagus and gastric cardia. JAMA (1995) 2.68

Prevalence and socioeconomic impact of upper gastrointestinal disorders in the United States: results of the US Upper Gastrointestinal Study. Clin Gastroenterol Hepatol (2005) 2.68

Prevalence, clinical spectrum and health care utilization of gastro-oesophageal reflux disease in a Chinese population: a population-based study. Aliment Pharmacol Ther (2003) 2.30

Asia-Pacific consensus on the management of gastroesophageal reflux disease: update. J Gastroenterol Hepatol (2008) 2.28

No relation between body mass and gastro-oesophageal reflux symptoms in a Swedish population based study. Gut (2000) 2.16

Symptoms of gastro-oesophageal reflux: prevalence, severity, duration and associated factors in a Spanish population. Aliment Pharmacol Ther (2004) 2.13

Obesity and chronic gastrointestinal tract symptoms in young adults: a birth cohort study. Am J Gastroenterol (2004) 2.05

Hiatal hernia, reflux symptoms, body size, and risk of esophageal and gastric adenocarcinoma. Cancer (2003) 2.03

Zero-inflated models for regression analysis of count data: a study of growth and development. Stat Med (2002) 1.98

Prevalence of symptoms suggestive of gastro-oesophageal reflux disease in an adult population. Ann Med (1995) 1.97

Genetic influences in gastro-oesophageal reflux disease: a twin study. Gut (2003) 1.85

Anxiety but not depression determines health care-seeking behaviour in Chinese patients with dyspepsia and irritable bowel syndrome: a population-based study. Aliment Pharmacol Ther (2002) 1.71

Three-month prevalence rates of gastrointestinal symptoms and the influence of demographic factors: results from the Domestic/International Gastroenterology Surveillance Study (DIGEST). Scand J Gastroenterol Suppl (1999) 1.69

Heartburn and globus in apparently healthy people. Can Med Assoc J (1982) 1.58

The association between obesity and GERD: a review of the epidemiological evidence. Dig Dis Sci (2008) 1.49

Elevated body mass disrupts the barrier to gastroesophageal reflux; discussion 1018-9. Arch Surg (2001) 1.37

Prevalence, clinical spectrum and atypical symptoms of gastro-oesophageal reflux in Argentina: a nationwide population-based study. Aliment Pharmacol Ther (2005) 1.32

Reflux-inducing dietary factors and risk of adenocarcinoma of the esophagus and gastric cardia. Nutr Cancer (2000) 1.23

Systematic review: the impact of gastro-oesophageal reflux disease on work productivity. Aliment Pharmacol Ther (2006) 1.20

A population-based survey of the epidemiology of symptom-defined gastroesophageal reflux disease: the Systematic Investigation of Gastrointestinal Diseases in China. BMC Gastroenterol (2010) 1.16

Prevalence and impact of symptoms suggestive of gastroesophageal reflux disease. Dig Dis Sci (1999) 1.14

Gastroesophageal reflux disease in Asia: A historical perspective and present challenges. J Gastroenterol Hepatol (2011) 1.07

Systematic investigation of gastrointestinal diseases in China (SILC): validation of survey methodology. BMC Gastroenterol (2009) 1.03

Managing gastroesophageal reflux disease in primary care: the patient perspective. J Am Board Fam Pract (2005) 1.02

Association of body mass index with heartburn, regurgitation and esophagitis: results of the Progression of Gastroesophageal Reflux Disease study. J Gastroenterol Hepatol (2007) 0.99

Impact of body mass index and gender on quality of life in patients with gastroesophageal reflux disease. World J Gastroenterol (2012) 0.94

Association between weight gain and symptoms of gastroesophageal reflux in the general population. Am J Gastroenterol (2006) 0.93

Validation of a survey methodology for gastroesophageal reflux disease in China. BMC Gastroenterol (2008) 0.92

Value of heartburn for diagnosing gastroesophageal reflux disease in severely obese patients. Obesity (Silver Spring) (2006) 0.88

Value of reflux diagnostic questionnaire in the diagnosis of gastroesophageal reflux disease. Chin J Dig Dis (2004) 0.87

Unmet treatment needs of gastroesophageal reflux disease in Asia: gastroesophageal reflux disease in Asia Pacific survey. J Gastroenterol Hepatol (2014) 0.87

Risk factors on the development of new-onset gastroesophageal reflux symptoms. A population-based prospective cohort study: the HUNT study. Am J Gastroenterol (2015) 0.85

Symptoms and quality of life in underweight gastroesophageal reflux disease patients and therapeutic responses to proton pump inhibitors. J Gastroenterol Hepatol (2012) 0.79

Prevalence of symptoms of gastroesopahgeal reflux in a cohort of Saudi Arabians: a study of 1265 subjects. Saudi J Gastroenterol (2014) 0.78

Articles by these authors

Body mass index and health-related quality of life in adults: a population based study in five cities of China. Eur J Public Health (2011) 0.94

Alcohol intake and associated risk of major cardiovascular outcomes in women compared with men: a systematic review and meta-analysis of prospective observational studies. BMC Public Health (2015) 0.92

Distribution of C-reactive protein and its association with cardiovascular risk factors in a population-based sample of Chinese. Dis Markers (2010) 0.84

Epidemiology of Functional abdominal bloating and its impact on health related quality of life: male-female stratified propensity score analysis in a population based survey in mainland China. PLoS One (2014) 0.80

Adult weight gain and risk of prostate cancer: A dose-response meta-analysis of observational studies. Int J Cancer (2015) 0.76

Associations Between Excessive Daytime Sleepiness and Functional Gastrointestinal Disorders: A Population-based Study in China. J Neurogastroenterol Motil (2016) 0.75

Effect and safety of dual anti-human epidermal growth factor receptor 2 therapy compared to monotherapy in patients with human epidermal growth factor receptor 2-positive breast cancer: a systematic review. BMC Cancer (2014) 0.75

Overview of phase IV clinical trials for postmarket drug safety surveillance: a status report from the ClinicalTrials.gov registry. BMJ Open (2016) 0.75

Smoking as a Risk Factor for the Occurrence of Atrial Fibrillation in Men Versus Women: A Meta-Analysis of Prospective Cohort Studies. Heart Lung Circ (2017) 0.75